Scopus BioPharma Inc. Quarterly Return On Assets in % from Q2 2021 to Q2 2023

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Scopus BioPharma Inc. quarterly/annual Return On Assets history and growth rate from Q2 2021 to Q2 2023.
  • Scopus BioPharma Inc. Return On Assets for the quarter ending June 30, 2023 was -1.2K %, a 248% decline year-over-year.
  • Scopus BioPharma Inc. annual Return On Assets for 2022 was -655 %, a 68% decline from 2021.
Return On Assets, Quarterly (%)
Return On Assets, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q2 2023 -1.2K -852 -248% Apr 1, 2023 Jun 30, 2023
Q1 2023 -921 -443 -92.8% Jan 1, 2023 Mar 31, 2023
Q4 2022 -655 -265 -68% Oct 1, 2022 Dec 31, 2022
Q3 2022 -441 -39.8 -9.94% Jul 1, 2022 Sep 30, 2022
Q2 2022 -344 +112 +24.6% Apr 1, 2022 Jun 30, 2022
Q1 2022 -477 Jan 1, 2022 Mar 31, 2022
Q4 2021 -390 Oct 1, 2021 Dec 31, 2021
Q3 2021 -401 Jul 1, 2021 Sep 30, 2021
Q2 2021 -456 Apr 1, 2021 Jun 30, 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.